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telomere length (tL) regulation is an important factor in ageing, reproduction and cancer development. 
Genetic, hereditary and environmental factors regulating tL are currently widely investigated, 
however, their relative contribution to tL variability is still understudied. We have used whole 
genome sequencing data of 250 family trios from the Genome of the Netherlands project to perform 
computational measurement of tL and a series of regression and genome-wide association analyses 
to reveal TL inheritance patterns and associated genetic factors. Our results confirm that TL is a 
largely heritable trait, primarily with mother’s, and, to a lesser extent, with father’s tL having the 
strongest influence on the offspring. In this cohort, mother’s, but not father’s age at conception was 
positively linked to offspring TL. Age-related TL attrition of 40 bp/year had relatively small influence on 
TL variability. Finally, we have identified TL-associated variations in ribonuclease reductase catalytic 
subunit M1 (RRM1 gene), which is known to regulate telomere maintenance in yeast. We also highlight 
the importance of multivariate approach and the limitations of existing tools for the analysis of tL as a 
polygenic heritable quantitative trait.
The terminal regions of linear human chromosomes are composed of telomeres - sequences of tandem TTAGGG 
repeats normally stretching around 10–15 kb in length. They protect the chromosomes from degradation and 
end-to-end fusions1 and perform a number of regulatory functions, including regulation of gene expression2, 
DNA damage response3, modulation of cellular senescence4, proper chromosome anchoring to the nuclear mem-
brane and segregation during meiosis5. Accordingly, changes in telomere length (TL) have been linked to devel-
opment of age-related diseases and cancers6–9.
TL regulation is a complex phenomenon that depends on a number of variables, such as age10, genetic11,12 
and environmental13,14 factors, and the tissue under study15,16. Initially, the idea of telomere length dependence 
on chronological age was based on the fact that in most somatic cells, telomeres get shorter over an individual’s 
lifespan, mostly due to telomere end-resection that occurs after each round of DNA replication17,18. However, 
while telomere attrition is associated with cellular senescence, it’s not completely clear how TL is linked to organ-
ismal ageing19. Particularly, inverse correlation of TL with age has been shown to be true for some20,21, but not for 
all populations22,23. Our previous study on South Asian genomes has identified no relationship with age in this 
population23, confirming previous observations suggesting that age-dependency of telomere length might be 
population-specific22.
Genetic factors influencing TL have been identified by multiple genome-wide association studies, both in 
healthy and in diseased populations11,12. Single nucleotide variations (SNVs) in several loci, such as telomer-
ase components TERT and TERC, and others (OBFC1, RTEL1, etc.) have been linked to TL11,24,25. For many 
loci, however, the identified associations with telomere length are either irreproducible in other cohorts or show 
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population-specificity26. Additionally, a number of environmental factors, such as stress, exposure to oxidative 
agents, smoking, alcohol consumption and lifestyle, all affect telomere attrition rate13,14.
Finally, while telomere length regulation and environmental factors affect TL variability in a lifetime of a single 
individual, TL variability between individuals is also largely explained by inheritance of parental telomeres and 
variable TLs at birth, with a stronger link between offspring and either father’s27, or mother’s28 TL. Additionally, 
paternal (PAC) and maternal (MAC) ages at conception also affect TL in the offspring29. This has mostly been 
shown for PAC, and explained by relatively longer TL in the sperm of older males27,30,31. A recent study has simu-
lated this effect across many generations and has suggested this as a mechanism for adaptation to cancer32.
Overall, based on their importance in healthy ageing and in regulation of basic cellular functionality, tel-
omeres are being extensively studied for their role in development of age-related diseases, cancers and reproduc-
tion6,10,24,25. Involvement of multiple genetic and environmental factors and heritability of TL largely complicates 
investigation of TL regulation and necessitates multi-factor analysis. We have previously studied TL in the 
South Asian population, based on whole genome sequencing (WGS) data. In this population, we have identified 
TL-associated loci in the ADARB2 gene, but did not reveal relation of TL with age23. That dataset, however, did 
not allow for analysis of TL inheritance patterns. Here, we make use of whole-blood derived DNA sequencing 
data generated by the Genome of the Netherlands (GoNL) project that involves WGS and SNV datasets from 250 
families, comprising trios of a mother, a father and a child. Importantly, this dataset was annotated not only for 
ages of individuals at the time of data collection, but also for parental ages at conception33. We have measured 
mean telomere length (MTL) from WGS data using Computel34, and have performed a number of regression 
analyses to identify age association and inheritance patterns of MTL in the Dutch population, and to reveal 
MTL-associated genomic loci.
Results
Population stratification. Principal component analysis on SNVs was previously performed by the GoNL 
consortium33. They had identified a subtle substructure of the population according to geographical origin of the 
individuals (along the north-south axis of the Netherlands). However, there were no distinct clusters and the first 
and the second principal components explained very little variation in the genotype data (~0.25% and ~0.24%, 
respectively). Therefore, we have performed downstream association analyses with the assumption of a homog-
enous population.
Regression analysis. In the studied population, MTL ranged from as low as 1.7 to 12 kbp in length. Multiple 
linear regression (MLR) analysis (with the model MTL ~Age + Sex) on all study subjects, including the MTL of 
parents and children, has shown that age is negatively correlated with MTL (adjusted R2 = 0.14, p value < 2.2e-
16), with an estimated attrition rate of ~ 40 bp per year, in agreement with prior observations10,35 (Fig. 1). On the 
other hand, contrary to studies commonly reporting longer telomeres in adult women compared to men36, in 
our cohort sex was not a significant predictor of MTL. Even though females on average had longer telomeres in 
our population (5.9 ± 1.6 kb in females versus 5.7 ± 1.6 kb in males, t-test p value = 0.03), this is likely due to age 
differences, as women were generally younger than men (by 4 years, t test p value < 0.001). Indeed, this difference 
was gone after adjustment for age by testing the mean difference in MTLs between males and females in each age 
group (females on average had 200 bp longer MTL, but with t-test p value 0.24).
Next, we have performed a series of MLRs to analyze the inheritance patterns of maternal and paternal tel-
omeres, using MTL of children as an outcome variable and MTL of parents as predictors. For each child in our 
dataset, we had information regarding their age and MTL, maternal MTL (mMTL), paternal MTL (fMTL), as well 
as mother’s and father’s ages at conception (MAC and PAC). Pairwise correlation analysis for all these predictors 
(Supplementary Fig. S1) have shown that many variables were not independent, with mother’s and father’s, as 
well as with parents’ and child’s ages showing strong correlation, and MTL, mMTL and fMTL being correlated 
with each other. In order to avoid collinearity related biases, we have constructed and tested simple and complex 
models including one to many predictors, as well as interaction terms. Among the models with highest adjusted 
R2 value, were the simple model MTL ~Age + mMTL + fMTL + MAC + PAC (adj. R2 = 0.442, Supplementary 
Figure 1. Negative association of telomere length with age. Combined analysis of children and parents shows 
~40 bp reduction in MTL per year. Sex was not significantly associated with MTL after adjustment for age. 
Overall, age explains only 14% of MTL variability among individuals.
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Table S1), and two complex models including interaction terms. As the goodness of fit and predictors’ correlation 
coefficients were quite close to each other among these models, we have chosen the simple one for interpretability 
(see Supplementary Table S1). Exploration of regression estimates for each predictor shows that age is correlated 
with a scaled estimate of −0.34 when it’s the only predictor in the model. However, its influence gets three times 
weaker after inclusion of mother’s and father’s MTLs, which are stronger predictors of child’s MTL (single-model 
estimates 0.58 and 0.51, respectively).
The final model explained only 44% of the variability in the offspring MTLs (Fig. 2A), with the strongest 
correlate being mother’s MTL (correlation estimate = 0.42), and to a lesser extent – father’s (correlation estimate 
= 0.25). In this model, age was still negatively correlated with MTL, however with smaller regression estimate of 
only −0.13 (Fig. 2B). Interestingly, MAC was significantly and positively correlated with child’s MTL (0.25), while 
PAC was not a significant predictor. The observed association between MAC and child’s MTL still preserved after 
accounting for the rest of the variables with partial correlation analysis (partial correlation estimates for the asso-
ciation with offspring MTL after adjustment for the rest of the factors were −0.16 (Age, p < 0.05), 0.42 (mMTL, 
p < 0.001), 0.26 (fMTL, p < 0.001), 0.19 (MAC, p < 0.01) and −0.06 (PAC, p > 0.05).
telomere length qtL analysis. Family based quantitative trait association analyses with MTL were per-
formed with Plink and Merlin. The lists of identified top SNVs are available in Supplementary Datasheet S1. 
Plink revealed three SNVs significantly associated with telomere length (FDR < 0.1): rs1285767 (CCDC88C), 
rs185870422 (non-coding region on chromosome 5) and rs1042858 (RRM1) (Fig. 3). The current version of 
Plink (version 1.9) did not allow for inclusion of additional covariates, namely age, in the family based MTL asso-
ciation analysis. Thus, we have also performed family association tests with Merlin to obtain independent assess-
ments of qTL. Merlin did account for age as a covariate, however, did not account for mendelian heritability of 
MTL. Thus, no SNVs were identified as significantly associated with MTL with this test. This is in accordance with 
MTL inheritance patterns revealed by MLR analysis described above, as telomere inheritance factors, particularly 
Figure 2. Multiple linear regression estimates for the best fit model of telomere length inheritance. (A) The actual 
MTL length of the offspring and the MTL predicted with the best fit model of telomere length inheritance: MTL 
~ Age + mMTL + fMTL + MAC + Age. (B) The correlation estimates, and p values for MTL with offspring age, 
maternal and paternal MTL (mMTL, fMTL) and maternal and paternal ages at conception (MAC, PAC) are 
presented, along with general statistics for the test (bottom). Significant correlations are marked with one, two 
and three asterisks, for p values of < 0.05, <0.01 and <0.001, respectively. Note, that PAC was not a significant 
predictor in the model: its estimates are presented for the reader’s information.
Figure 3. Manhattan plot for significance of SNV association with MTL. Analysis were performed with Plink 
family based association tests, with additive model for SNVs. Three SNVs (rs185870422 – chromosome 5q, 
rs1042858 – RRM1, rs1285767 – CCDC88C) are significantly associated with MTL at false discovery rate of 0.1.
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mother’s and father’s MTL and MAC (correlation coefficients 0.42, 0.25 and 0.25), are stronger predictors of MTL 
than age (correlation coefficient −0.13).
Taking into consideration the limitations of these two methods, we have also performed multiple linear regres-
sion tests for each SNV, by adding child’s genotype for each SNV to the MLR model obtained above: MTL ~Age 
+ mMTL + fMTL + MAC + PAC + SNV. Here each SNV takes on values from 0 to 2, depending on the number 
of dominant alleles in a child’s genotype. These tests revealed only six SNVs residing within the DSCAM gene, 
associated with offspring MTL after adjustment for all the variables included in the MLR model. With this model, 
only two top SNVs from Plink association tests had significant association p values (unadjusted) (rs185870422 
(chr5q) and rs1285767 (CCDC88C)). The results for these two SNVs and DSCAM were further confirmed by 
Plink linear regression test performed on the population of children only. Isolated Plink linear regression tests on 
the parents’ population did not reveal any significant quantitative loci after multiple comparison test adjustment 
(Fig. 4, Supplementary Datasheet S1).
One of the three loci identified by Plink, rs1285767, resides within the CCDC88C gene and leads to 514 bp 
gain of MTL per additional minor allele. CCDC88C encodes the protein Daple that is known to regulate the 
non-canonical Wnt signaling pathway, which plays an important role in embryonic development, cell motility 
and tumor progression37,38. Wnt signaling pathway is a known regulator of telomerase activity through its cen-
tral player β-catenin, which binds transcription factors and regulates expression of TERT, the catalytic subunit 
of telomerase39. Nonetheless, the SNV is positioned intronically and its functional effects are unknown. This 
locus came out as a significant MTL-associated hit not only in Plink family association analysis, but was also 
border-line significant in separate Plink regression analyses on the populations of parents and children. The 
presence of minor alleles shows consistent additive effects on MTL in family and parent/children groups (Fig. 4).
Figure 4. Significance and genotype effects of MTL-associated SNVs. Colors are used to delineate each SNV. 
The dark-to-light color gradient indicates low-to-high p values (raw p values from each test). The value of 
1 × 10−7 (E-07) corresponds to FDR threshold of 0.1. Family tests with Merlin only accounted for coding 
regions, therefore no p-value for the SNV at chr5q was available for this test. The DSCAM gene was identified 
with six SNVs (rs11701674, rs28412810, rs11700591, rs62237637, rs11702319), which, however, were linked 
and showed similar patterns represented here with rs11701674 only. Boxplots show MTL values for each 
individual (in all the samples, or in children or parent only), depending on the amount of minor alleles for each 
SNV in the genotype. Significant MTL differences between genotypes are highlighted with asterisks. All the 
SNVs show consistent effect in parents and in children, with the minor allele of SNV at chr5q having negative, 
while that of the other three SNVs having positive association with MTL.
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The next locus identified by Plink-based family tests, as well as by Plink linear regression analysis on parent/
children groups was rs185870422, residing in a non-coding region on the q arm of chromosome 5. Interestingly, 
no individual had a homozygous genotype for the minor allele of this SNV. However, the heterozygotes had 
consistently lower MTL (by 1000 bp) than homozygotes for the major allele (Fig. 4). This locus distantly interacts 
with UBLCP1 and RNF145 genes within the same chromatin loop (source: database 3DSNP version 1.0). Those, 
however, do not have known roles in telomere length regulation.
The RRM1 locus was the most consistent hit in Plink family tests, with 75 SNVs having border-line signifi-
cance (raw p value < 10−6–10−5), in contrast to CCDC88C, which had only two SNVs with raw p values < 10−5 
(Fig. 4, Supplementary Datasheet S1). The rs1042858 variant of RRM1 had positive effect on MTL (892 bp per 
locus), but, it was only identified during Plink family association tests and separate regression tests on parents 
(Fig. 4). Homozygotes for the minor allele were missing among children, but the presence of the minor allele in 
heterozygotes had the same positive effect on MTL. According to Ensembl Variant Effect Predictor results, this 
variant is synonymous to the standard transcript of RRM1, but can, however, introduce a modification at the 3′ 
UTR of its alternative transcript (ENST00000532170.5) that may affect nonsense-mediated decay.
The six SNVs revealed by the MLR model tests (rs11701674, rs28412810, rs11700591, rs62237637, 
rs11702319) were all linked and resided within intronic regions of the Down Syndrome cell adhesion molecule 
(DSCAM) gene), which encodes an immunoglobulin superfamily member, is involved in axon guidance and is a 
candidate for Down syndrome and congenital heart disease40. The amount of homozygotes for the minor alleles of 
these SNVs was low, and their effect on TL was only seen in children. In the MLR inheritance model, the regres-
sion coefficient for these SNVs was higher (0.67) compared to all other variables (mMTL had a correlation coef-
ficient of 0.42 after addition of these SNVs). However, addition of these SNVs to the MLR model increased the 
percentage of explained variation in offspring MTL by only 6% (leading to regression R2 of 50%, Supplementary 
Datasheet S1). Note that while this analysis did account for all the available covariates, it didn’t account for family 
structure and, thus, had low statistical power.
Discussion
Telomeres are attractive targets for aging, cancer research and reproductive medicine6–9. Since their discovery, 
a large number of studies have addressed the biology of their inheritance27–29 and the causes of inter-individual 
variation of telomere length, including genetic and environmental factors10–14. These studies have shown that 
telomere length is a largely heritable trait, and is also affected by both environmental and genetic factors in a 
population-specific manner22,23,26. Due to involvement of the mentioned factors in telomere length variation, 
consistency of results across studies strongly depends on the study design, particularly on inclusion of families 
and multivariate analysis.
Here, we have analyzed whole genome sequencing data obtained by the genome of the Netherlands (GoNL) 
project, which included 250 Dutch family trios with associated meta-information on sex, age, paternal and mater-
nal ages at conception. We have used computational means for estimation of telomere length and have performed 
a series of regression and quantitative trait association analyses to reveal inheritance patterns of telomeres and to 
identify genetic variations affecting their length.
While age plays a role in telomere length variation during a lifetime, our analysis show that its effect is weaker 
compared to inheritance factors, namely parental telomere lengths, with mother’s telomeres being the strongest 
predictors of offspring MTL. The observed highly heritable nature of telomeres is in agreement with prior stud-
ies performed on twins, showing that lymphocyte telomere length at birth largely determines inter-individual 
variation, while factors regulating telomeres during lifetime are of less importance12,41. However, whether length 
inheritance occurs stronger through paternal27 or, as in our case, through maternal line28, is still a controversy.
Our results also show positive association of maternal age at conception (MAC) with offspring MTL. Previous 
studies have largely linked paternal age at conception (PAC) with offspring TL29. This association has been 
explained by positive selection of sperm cells with longer telomeres with increasing age in males27,30,31. There 
is limited evidence on MAC effect on offspring TL due to high correlation between biological ages of partners 
and the difficulty to assess TL dynamics in healthy female oocytes36. Most studies perform regression analysis to 
support the hypothesis of PAC association with TL and monitor changes in PAC estimates before and after adjust-
ment for MAC40. Our observation of positive association of MAC with offspring MTL was also confirmed after 
partial correlation analysis. It is a matter of future investigations to find out the causes for such a link: whether 
MAC directly affects TL in oocytes or is indirectly involved in TL regulation in the embryo.
All in all, in the studied population, offspring MTL is positively affected by maternal and paternal MTL and 
MAC. While these correlations could partially reflect mendelian inheritance of telomeres32, those could also 
depend on inheritance of genetic factors regulating TL. Identification of telomere-related genetic variants in our 
cohort was not trivial, due to multiple factors of TL variability that should be accounted for when performing 
such studies in families. In particular, family association tests implemented in Plink did not allow for inclusion of 
age as a confounder, while Merlin did not account for heritability of telomeres as quantitative traits. Furthermore, 
inclusion of genotypes for each SNV into our multiple linear regression model for TL inheritance did not account 
for family structure. These limitations, along with the small sample size, reduced the statistical power of our tests. 
Nevertheless, the only consistent hit – RRM1 – was identified by Plink-based analysis, where age was the missing 
confounder. This once again confirmed the relatively small influence of age on TL variability among other factors.
RRM1 encodes the catalytic subunit of ribonucleotide reductase (RNR), an enzyme essential for dNTP synthe-
sis and DNA replication and repair processes42. In humans, the role of RRM1 in telomere length regulation is not 
established yet. However, it is known that the yeast ortholog of this gene, Rnr1, is required for telomerase func-
tionality, possibly via facilitation of telomere synthesis via local temporary boosts of dNTPs43. Our data, thus, sug-
gests that RRM1 may also be involved in telomere length regulation in humans. Importantly, it is known that in 
humans, RRM1 is involved in regulation of cellular proliferation, migration and cancer progression, presumably 
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due to its role in DNA replication44. It is also targeted by certain chemotherapeutics or used as a biomarker to 
predict their effectiveness44–46. Furthermore, polymorphisms and altered expression of this gene have been linked 
to increased susceptibility to certain cancers45,47. RRM1’s role in cancer, however, is only discussed in terms of its 
involvement in DNA synthesis, and not in terms of telomere length regulation. This study, thus, may serve as a 
basis for extending the functional studies on RRM1 to telomeres as well.
conclusions
All in all, the well-structured and richly annotated dataset provided by the Genome of the Netherlands project has 
allowed us to reveal several aspects of telomere length inheritance and variability. We have shown that parents’ 
telomere lengths and mother’s age at conception play an important role in defining telomere length variability 
among individuals, along with age and genetic factors. Additionally, our results on association of RRM1 with 
MTL and prior studies on its ortholog in yeast, suggest possible implications for this gene in telomere biology in 
humans.
We also highlight the limitations of currently available computational tools for performing genome-wide asso-
ciation studies on heritable quantitative traits in family trio datasets. Development of these tools and emergence 
of sequencing datasets on family trios from other populations will further allow for delineating common and 
population-specific factors involved in telomere length regulation.
Methods
Datasets. We make use of secondary analysis of whole genome sequencing (WGS) data (http://www.nlge-
nome.nl/, European Genome-phenom Archive, EGAS00001000644) previously generated by the Genome of the 
Netherlands Project (GoNL). The WGS data had been produced on Illumina HiSeq. 2000 platforms with 12x 
coverage. It consisted of 748 Dutch individuals forming trios of a mother, a father and a child. We also had infor-
mation about their age and sex, as well as the ages of conception for the mothers and the fathers.
Single nucleotide variation (SNV) data was obtained from the release 5.4 of the GoNL project, where variant 
calling had been performed on hg19 assembly of the reference genome by the GoNL Consortium33.
SNV filtering. We have accounted for SNV data passing the filters with VCFtools version 0.1.14, and have 
removed SNVs with minor allele frequency <5% (70.8% of all SNVs), those with missingness values of <10% 
(0.3% of all SNVs) and those not passing Hardy-Weinberg equilibrium significance threshold of 0.001 (1.2% of 
all SNVs) using Plink version 1.9. Overall, genotype information for 5352580 SNVs for 748 individuals were 
included in the downstream analyses.
telomere length calculation. We have calculated mean telomere lengths (MTL) from whole genome 
sequencing data using Computel version 0.4 with its default parameters34. Computel determines MTL by align-
ment to a special telomeric reference and by comparing the coverage at the telomeric reference to the coverage 
at the genome reference34. The WGS data contained multiple runs per individual, and we have taken the median 
MTL per individual across multiple runs.
Regression analysis. Multivariate linear regression analysis was performed to evaluate the correlation 
between MTL and age and sex in the studied population. Another MLR model was analyzed to study the inher-
itance of maternal and paternal MTL, as well as the role of MAC and PAC on offspring MTL. Two of the families 
with missing data for the mother were removed, and two families with discordant age differences at the time of 
data collection and at conception were also discarded. Overall, MLR were done on 246 families. A set of pairwise 
regressions on the predictors were performed to estimate dependence between variables, and interaction terms 
were introduced for correlated predictors. The MLR models were tested by sequential introduction of predictors 
and interaction terms. The best model was chosen based on maximization of the adjusted R square term: ulti-
mately, from the three best models with similar adjusted R squared values the simplest one was chosen. Partial 
correlation analyses were performed with R package ppcor and were used to estimate the influence of each pre-
dictor when accounting for the rest of the predictors in the model.
telomere qtL analysis. Association of single nucleotide variations (SNV) with MTL was performed with 
family based association tests for quantitative traits implemented in Plink 1.948 and Merlin 1.1.249, as well as with 
a series of MLR models. Both, Merlin and Plink use the between/within model implemented in the QTDT pack-
age50. However, Merlin uses a maximum likelihood variance component model to correct for family structure, 
while Plink uses a procedure based on permutations.
We ran Plink with the qfam-total option for identification of quantitative associations with adjustment for sex, 
and with 100 000 000 permutations to adjust for family structure. One drawback of this approach is that Plink 
does not handle covariates (other than sex) for family associations, which did not allow to adjust for age. As age 
was affecting telomere length in our analysis (see Results), we also ran a number of alternative tests.
Separate linear regression tests for parents and children were performed with Plink quantitative association 
tests, using an additive model for variants and treating age and sex as covariates.
To perform family association tests accounting for age, we used Merlin. For this, we have downloaded genetic 
maps of 1000 genomes project variants generated by Hapmap 2 project that involved average recombination 
rates in three different populations (CEU, YRI, and ASN) (from https://github.com/joepickrell/1000-geno
mes-genetic-maps). Only the coding SNVs were included in these tests, and those SNVs with mendelian errors 
were marked as missing. While Merlin accounted for age, it had the disadvantage of not accounting for quanti-
tative trait inheritance, i.e. inheritance of telomere lengths from parents to offspring, as well as being limited to 
variants for which recombination rate information is available.
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Finally, we also ran multiple linear regression (MLR) analysis by incorporating an additive model of child’s 
genotype for each variant (a variable taking on values from 0 to 2, according to the number of minor alleles in 
the genotype) into the MLR model of telomere length inheritance obtained from MLR analysis described above. 
While these regression models do not account for variant linkage and thus had lower statistical power, they do 
consider telomere length inheritance, age and family structure.
Data availability
This study makes use of the data generated by the Genome of the Netherlands Project. A full list of the investigators 
is available from www.nlgenome.nl. The datasets analyzed during the current study are available in the European 
Genome-phenome Archive repository, https://www.ebi.ac.uk/ega/studies/EGAS00001000644.
The scripts used for the analyses are available in Github, at https://github.com/lilit-nersisyan/gonl_tqtl.
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